ButlerJ., AttiyehF.F., DalyJ.M.Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet.1986; 162: 109–113.
2.
BallantyneG.H., QuinJ.Surgical treatment of liver metastases in patients with colorectal cancer. Cancer.1993; 71(Suppl 12): 4252–4266.
3.
BaumR.P., LorenzM., HootenrottC.Immunoscintigraphy and continuous regional chemotherapy of liver metastases: a prospective study controlled by surgery, histology and immunohistochemistry. J Nucl Med.1987; 28: 35–42.
4.
TurkP.S., WaneboH.J.Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer.1993; 71(Suppl 12): 4267–4277.
5.
DoerrR.J., HerreraL., Abdel-NabiH.In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer. Cancer.1993; 71(Suppl 12): 4241–4247.
6.
CollierB.D., Abdel-NabiH., DoerrR.J.Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with computed tomography. Radiology.1992; 185: 179–186.
7.
DoerrR.J., Abdel-NabiH., KragD.Radiolabeled antibody imaging in the management of colorectal cancer: results of a multicenter clinical study. Ann Surg.1991; 214: 118–124.
8.
NealC.E., MeisL.C.Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer. Semin Nucl Med.1994; 24: 272–285.
9.
TemperoM.Pitfalls in antibody imaging in colorectal cancer. Cancer.1993; 71(Suppl 12): 4248–4251.
10.
Abdel-NabiH.H., ChanH.W., DoerrR.J.Indium-labeled anti-colorectal carcinoma monoclonal antibody accumulation in non-tumored tissue in patients with colorectal carcinoma. J Nucl Med.1990; 31: 1975–1979.
11.
DoerrR.J., Abdel-NabiH., KragD.Radiolabeled antibody imaging in the management of colorectal cancer: results of a multicenter clinical study. Ann Surg.1991; 214: 118–124.
12.
Abdel-NabiH.H., DoerrR.J., ChanH.W.Safety and role of repeated administrations of Indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE 025 in the postoperative follow-up of colorectal carcinoma patients. J Nucl Med.1992; 33: 14–22.
13.
WinzelbergG.G., GrossmanS.J., RizkS.Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer: correlation with computed tomography, surgery, histopathology, immunohistology and human immune response. Cancer.1992; 69: 1656–1663.
14.
RyanJ.W.Immunoscintigraphy in primary colorectal cancer. Cancer.1993; 71(Suppl 12): 4217–4224.
15.
PattY.Z.D.A., CurleyS.Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen: experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials. Cancer.1993; 71(Suppl 12): 4293–4297.
16.
SardiA., WorkmanM., MojzisikC.Intra-abdominal recurrence of colorectal cancer detected by radioimmunoguided surgery (RIGS system). Arch Surg.1989; 124: 55–59.
17.
HouchensD., CoteR., SaadA.Radioimmunoguided surgery in colorectal cancer: histologic and immunochemical analysis of lymph nodes from patients injected with 125-I labelled monoclonal antibody CC49. Presented at the Seventh International Conference on Monoclonal Antibody Immunoconjugates for Cancer, San Diego, Calif. March 5–7, 1992.
18.
CohenA.M., MartinE.W.Jr, LaveryI.Radioimmunoguided surgery using Iodine 125 B72.3 in patients with colorectal cancer. Arch Surg.1991; 126: 349–352.
19.
ArnoldM.W., SchneebaumS., MartinE.W.Jr. Radioimmunoguided surgery in the treatment and evaluation of rectal cancer patients. Cancer Cont: JMCC.1996; 3: 42–45.
